BNF:

6.1.2.3

Status:

Grey

Decision Date:

December 2014

Comments

GREY: See type 2 diabetes guidance (decision date: July 2023)

Renal function:

• Reduce the dose to 12.5mg daily if eGFR is between 30-50ml/min/1.73m²
• Reduce the dose to 6.25mg daily if the eGFR<30ml/min/1.73m²

Hepatic function:

• not recommended in severe hepatic impairment

search again